Elan Corp, plc (ADR) (NYSE:ELN)
| CAPS Rating |
|
|---|---|
| Open | $13.41 |
| Previous Close | $13.44 |
| Daily Range | $13.00 - $13.61 |
| 52-Week Range | $6.10 - $14.40 |
| Market Cap | $7.73B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 4,225,011 |
| Average Daily Volume | 0 |
ELN
VS S&P 500 (SPY)
How do you think ELN will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ELN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ELN News and Commentary
- The Gory Details on Elan's Double Miss – The Motley Fool
- The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and – NASDAQ
- Revenues Skyrocket at Merged Alkermes - Analyst Blog – NASDAQ
- Has Elan Become the Perfect Stock? – The Motley Fool
- The Disadvantage of a Successful Pipeline – The Motley Fool
- New Study for Alkermes' Vivitrol - Analyst Blog – NASDAQ
- The Zacks Analyst Blog Highlights: Pfizer, Biogen Idec, Elan, Novartis and Roche - Press Releases – NASDAQ
- EPS Beat for Biogen; Outlook Weak - Analyst Blog – NASDAQ
- 2nd UPDATE: Biogen 4Q Net Up 25%; Investing In Pipeline – SmartMoney
- UPDATE: Biogen 4Q Net Up 25% As Company Invests In Pipeline – SmartMoney
- Which Big Biotech Is the Best Bet? – The Motley Fool
- Biogen & Elan Announce Tysabri Trial - Analyst Blog – NASDAQ
- Earnings Preview: Biogen - Analyst Blog – NASDAQ
- Wall Street Needs to Get Behind These Stocks – The Motley Fool
- Elan, Biogen Start Phase 3 Billion Study To Evaluate Effectiveness Of Tysabri – SmartMoney
- Positive News for Biogen & Elan - Analyst Blog – NASDAQ
- 50% of This Market Would Be Just Fine – The Motley Fool
- Stocks on the Road to Greatness – The Motley Fool
- Biogen Preserves MS Drug's Sales With Label Change – Minyanville
- FDA Nod for Quest's STRATIFY JCV - Analyst Blog – NASDAQ
RSS Headlines
Fool UK
